Artigos de revistas sobre o tema "Epigenetic reprograming"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Epigenetic reprograming".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Lameirinhas, Ana, Vera Miranda-Gonçalves, Rui Henrique e Carmen Jerónimo. "The Complex Interplay between Metabolic Reprogramming and Epigenetic Alterations in Renal Cell Carcinoma". Genes 10, n.º 4 (2 de abril de 2019): 264. http://dx.doi.org/10.3390/genes10040264.
Texto completo da fonteAguirre-Vázquez, Alain, Luis A. Salazar-Olivo, Xóchitl Flores-Ponce, Ana L. Arriaga-Guerrero, Dariela Garza-Rodríguez, María E. Camacho-Moll, Iván Velasco, Fabiola Castorena-Torres, Nidheesh Dadheech e Mario Bermúdez de León. "5-Aza-2′-Deoxycytidine and Valproic Acid in Combination with CHIR99021 and A83-01 Induce Pluripotency Genes Expression in Human Adult Somatic Cells". Molecules 26, n.º 7 (29 de março de 2021): 1909. http://dx.doi.org/10.3390/molecules26071909.
Texto completo da fonteHabel, Nadia, Najla El-Hachem, Frédéric Soysouvanh, Hanene Hadhiri-Bzioueche, Serena Giuliano, Sophie Nguyen, Pavel Horák et al. "FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells". Cell Death & Differentiation 28, n.º 6 (18 de janeiro de 2021): 1837–48. http://dx.doi.org/10.1038/s41418-020-00710-x.
Texto completo da fonteBui, L. C., A. V. Evsikov, D. R. Khan, C. Archilla, N. Peynot, A. Hénaut, D. Le Bourhis, X. Vignon, J. P. Renard e V. Duranthon. "Retrotransposon expression as a defining event of genome reprograming in fertilized and cloned bovine embryos". REPRODUCTION 138, n.º 2 (agosto de 2009): 289–99. http://dx.doi.org/10.1530/rep-09-0042.
Texto completo da fontePilsner, J. Richard, Mikhail Parker, Oleg Sergeyev e Alexander Suvorov. "Spermatogenesis disruption by dioxins: Epigenetic reprograming and windows of susceptibility". Reproductive Toxicology 69 (abril de 2017): 221–29. http://dx.doi.org/10.1016/j.reprotox.2017.03.002.
Texto completo da fonteMerino, Aimee, Bin Zhang, Philip Dougherty, Xianghua Luo, Jinhua Wang, Bruce R. Blazar, Jeffrey S. Miller e Frank Cichocki. "Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming". Journal of Clinical Investigation 129, n.º 9 (12 de agosto de 2019): 3770–85. http://dx.doi.org/10.1172/jci125916.
Texto completo da fonteZhang, Zhiren, Yanhui Zhai, Xiaoling Ma, Sheng Zhang, Xinglan An, Hao Yu e Ziyi Li. "Down-Regulation of H3K4me3 by MM-102 Facilitates Epigenetic Reprogramming of Porcine Somatic Cell Nuclear Transfer Embryos". Cellular Physiology and Biochemistry 45, n.º 4 (2018): 1529–40. http://dx.doi.org/10.1159/000487579.
Texto completo da fonteAmsalem, Zohar, Tasleem Arif, Anna Shteinfer-Kuzmine, Vered Chalifa-Caspi e Varda Shoshan-Barmatz. "The Mitochondrial Protein VDAC1 at the Crossroads of Cancer Cell Metabolism: The Epigenetic Link". Cancers 12, n.º 4 (22 de abril de 2020): 1031. http://dx.doi.org/10.3390/cancers12041031.
Texto completo da fonteMani, Sneha, e Monica Mainigi. "Embryo Culture Conditions and the Epigenome". Seminars in Reproductive Medicine 36, n.º 03/04 (maio de 2018): 211–20. http://dx.doi.org/10.1055/s-0038-1675777.
Texto completo da fonteByrne, Kristen A., Hamid Beiki, Christopher K. Tuggle e Crystal L. Loving. "β-glucan induced training and tolerance: alterations to primary monocytes". Journal of Immunology 200, n.º 1_Supplement (1 de maio de 2018): 59.17. http://dx.doi.org/10.4049/jimmunol.200.supp.59.17.
Texto completo da fonteNorman, Allison R., Grace Anne Ward, Caitlin C. Zebley e Ben A. Youngblood. "Effects of targeted epigenetic modifications on T – cell reprogramming". Journal of Immunology 210, n.º 1_Supplement (1 de maio de 2023): 148.09. http://dx.doi.org/10.4049/jimmunol.210.supp.148.09.
Texto completo da fonteAnderson, Juan, Mariah Delgado, Malcolm Lovett, Maya Saunders, Geovannie Lake, Samuel Darko, Rose M. Stiffin et al. "Abstract 859: Development of non-smoking lung cancers by indoor carcinogenic aerosols through epigenetic reprogramming of lung stem cells: Bioinformatics and artificial intelligence analysis". Cancer Research 84, n.º 6_Supplement (22 de março de 2024): 859. http://dx.doi.org/10.1158/1538-7445.am2024-859.
Texto completo da fonteLi, Mingli, e Chun-Wei Chen. "Epigenetic and Transcriptional Signaling in Ewing Sarcoma—Disease Etiology and Therapeutic Opportunities". Biomedicines 10, n.º 6 (5 de junho de 2022): 1325. http://dx.doi.org/10.3390/biomedicines10061325.
Texto completo da fonteKelly, Rebeca, Diego Aviles, Catriona Krisulevicz, Krystal Hunter, Lauren Krill, David Warshal e Olga Ostrovsky. "The Effects of Natural Epigenetic Therapies in 3D Ovarian Cancer and Patient-Derived Tumor Explants: New Avenues in Regulating the Cancer Secretome". Biomolecules 13, n.º 7 (1 de julho de 2023): 1066. http://dx.doi.org/10.3390/biom13071066.
Texto completo da fonteGehrmann, Ulf, Marianne Burbage, Elina Zueva, Christel Goudot, Cyril Esnault, Mengliang Ye, Jean-Marie Carpier et al. "Critical role for TRIM28 and HP1β/γ in the epigenetic control of T cell metabolic reprograming and effector differentiation". Proceedings of the National Academy of Sciences 116, n.º 51 (27 de novembro de 2019): 25839–49. http://dx.doi.org/10.1073/pnas.1901639116.
Texto completo da fonteFedoroff, Nina, Jo Ann Banks e Patrick Masson. "Molecular genetic analysis of the maize Suppressor-mutator element's epigenetic developmental regulatory mechanism". Genome 31, n.º 2 (15 de janeiro de 1989): 973–79. http://dx.doi.org/10.1139/g89-170.
Texto completo da fonteArif, Stern, Pittala, Chalifa-Caspi e Shoshan-Barmatz. "Rewiring of Cancer Cell Metabolism by Mitochondrial VDAC1 Depletion Results in Time-Dependent Tumor Reprogramming: Glioblastoma as a Proof of Concept". Cells 8, n.º 11 (28 de outubro de 2019): 1330. http://dx.doi.org/10.3390/cells8111330.
Texto completo da fonteAhmad, Aamir. "Corruptive Reprograming of Macrophages into Tumor-Associated Macrophages: The Transcriptional, Epigenetic and Metabolic Basis". Cancers 15, n.º 17 (28 de agosto de 2023): 4291. http://dx.doi.org/10.3390/cancers15174291.
Texto completo da fonteMunger, Karl, e D. Leanne Jones. "Human Papillomavirus Carcinogenesis: an Identity Crisis in the Retinoblastoma Tumor Suppressor Pathway". Journal of Virology 89, n.º 9 (11 de fevereiro de 2015): 4708–11. http://dx.doi.org/10.1128/jvi.03486-14.
Texto completo da fonteÖzbek, Rabia, Krishnendu Mukherjee, Fevzi Uçkan e Andreas Vilcinskas. "Reprograming of epigenetic mechanisms controlling host insect immunity and development in response to egg-laying by a parasitoid wasp". Proceedings of the Royal Society B: Biological Sciences 287, n.º 1928 (10 de junho de 2020): 20200704. http://dx.doi.org/10.1098/rspb.2020.0704.
Texto completo da fonteCorrêa, Régis L., Alejandro Sanz-Carbonell, Zala Kogej, Sebastian Y. Müller, Silvia Ambrós, Sara López-Gomollón, Gustavo Gómez, David C. Baulcombe e Santiago F. Elena. "Viral Fitness Determines the Magnitude of Transcriptomic and Epigenomic Reprograming of Defense Responses in Plants". Molecular Biology and Evolution 37, n.º 7 (7 de abril de 2020): 1866–81. http://dx.doi.org/10.1093/molbev/msaa091.
Texto completo da fonteDay, Charles, Alyssa Langfald, Florina Grigore, Sela Fadness, Leslie Sepaniac, Jason Stumpff, Kevin Vaughan, James Robinson e Edward Hinchcliffe. "DIPG-05. HISTONE H3.3 K27M IMPAIRS SER31 PHOSPHORYLATION, RESULTING IN CHROMOSOMAL INSTABILITY, LOSS OF CELL CYCLE CHECKPOINT CONTROL, AND TUMOR FORMATION". Neuro-Oncology 22, Supplement_3 (1 de dezembro de 2020): iii288. http://dx.doi.org/10.1093/neuonc/noaa222.057.
Texto completo da fonteKutschat, Ana P., Steven A. Johnsen e Feda H. Hamdan. "Store-Operated Calcium Entry: Shaping the Transcriptional and Epigenetic Landscape in Pancreatic Cancer". Cells 10, n.º 5 (21 de abril de 2021): 966. http://dx.doi.org/10.3390/cells10050966.
Texto completo da fonteSato, Hiromichi, Tomoaki Hara, Sikun Meng, Yoshiko Tsuji, Yasuko Arao, Kazuki Sasaki, Norikatsu Miyoshi et al. "Drug Discovery and Development of miRNA-Based Nucleotide Drugs for Gastrointestinal Cancer". Biomedicines 11, n.º 8 (9 de agosto de 2023): 2235. http://dx.doi.org/10.3390/biomedicines11082235.
Texto completo da fonteTanaka, Atsushi. "How to Improve Clinical Outcome in ROSI". Fertility & Reproduction 05, n.º 04 (dezembro de 2023): 275. http://dx.doi.org/10.1142/s2661318223740894.
Texto completo da fonteGoto, Norihiro, Saori Goto, Peter Westcott, Shinya Imada, Judith Agudo e Omer Yilmaz. "Abstract 1352: SOX17 plays a critical role in immune evasion of colorectal cancer". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 1352. http://dx.doi.org/10.1158/1538-7445.am2023-1352.
Texto completo da fonteRenatino-Canevarolo, Rafael, Mark B. Meads, Maria Silva, Praneeth Reddy Sudalagunta, Christopher Cubitt, Gabriel De Avila, Raghunandan R. Alugubelli et al. "Dynamic Epigenetic Landscapes Define Multiple Myeloma Progression and Drug Resistance". Blood 136, Supplement 1 (5 de novembro de 2020): 32–33. http://dx.doi.org/10.1182/blood-2020-142872.
Texto completo da fonteVelasquez-Vasconez, Pedro A., Benjamin J. Hunt, Renata O. Dias, Thaís P. Souza, Chris Bass e Marcio C. Silva-Filho. "Adaptation of Helicoverpa armigera to Soybean Peptidase Inhibitors Is Associated with the Transgenerational Upregulation of Serine Peptidases". International Journal of Molecular Sciences 23, n.º 22 (18 de novembro de 2022): 14301. http://dx.doi.org/10.3390/ijms232214301.
Texto completo da fonteWang, Zhishan, e Chengfeng Yang. "Metal carcinogen exposure induces cancer stem cell-like property through epigenetic reprograming: A novel mechanism of metal carcinogenesis". Seminars in Cancer Biology 57 (agosto de 2019): 95–104. http://dx.doi.org/10.1016/j.semcancer.2019.01.002.
Texto completo da fonteMa, Xuan, Feng Xing, Qingxiao Jia, Qinglu Zhang, Tong Hu, Baoguo Wu, Lin Shao, Yu Zhao, Qifa Zhang e Dao-Xiu Zhou. "Parental variation in CHG methylation is associated with allelic-specific expression in elite hybrid rice". Plant Physiology 186, n.º 2 (23 de fevereiro de 2021): 1025–41. http://dx.doi.org/10.1093/plphys/kiab088.
Texto completo da fonteKoul, Hari K., Mousa Vatanmakanian, Ellen Nogueira Lima, Lakshmi S. Chaturvedi e Sweaty K. Koul. "DNA methyl-transferases (DNMTs) as potential therapeutic vulnerability in prostate cancer." Journal of Clinical Oncology 42, n.º 4_suppl (1 de fevereiro de 2024): 339. http://dx.doi.org/10.1200/jco.2024.42.4_suppl.339.
Texto completo da fonteBitman-Lotan, Eliya, e Amir Orian. "Nuclear organization and regulation of the differentiated state". Cellular and Molecular Life Sciences 78, n.º 7 (28 de janeiro de 2021): 3141–58. http://dx.doi.org/10.1007/s00018-020-03731-4.
Texto completo da fonteJaune-Pons, Emilie, Zachary Klassen, Rachel Lu, Ye Shen, Nadeem Hussain, Michael Sey, Ken Leslie et al. "Abstract B067: Patient-specific differences in cancer-associated fibroblasts alter tumor organoid phenotype and chemosensitivity in pancreatic ductal adenocarcinoma". Cancer Research 84, n.º 2_Supplement (16 de janeiro de 2024): B067. http://dx.doi.org/10.1158/1538-7445.panca2023-b067.
Texto completo da fonteKelly, Rebeca, Diego Aviles, David Philip Warshal, Lauren Krill e Olga Ostrovsky. "Can epigenetic treatments efficiently revoke the ability of 3D ovarian cancer cells to proliferate, migrate, and invade?" Journal of Clinical Oncology 41, n.º 16_suppl (1 de junho de 2023): e17562-e17562. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e17562.
Texto completo da fonteFunk, Christopher Ronald, Shuhua Wang, Kevin Z. Chen, Alexandra Waller, Aditi Sharma, Claudia L. Edgar, Vikas A. Gupta et al. "PI3Kδ/γ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity". Blood 139, n.º 4 (27 de janeiro de 2022): 523–37. http://dx.doi.org/10.1182/blood.2021011597.
Texto completo da fonteHuang, Xin, Xudong Gao, Wanying Li, Shuai Jiang, Ruijiang Li, Hao Hong, Chenghui Zhao et al. "Stable H3K4me3 is associated with transcription initiation during early embryo development". Bioinformatics 35, n.º 20 (12 de março de 2019): 3931–36. http://dx.doi.org/10.1093/bioinformatics/btz173.
Texto completo da fonteSobolewski, Marissa, Garima Varma, Beth Adams, David W. Anderson, Jay S. Schneider e Deborah A. Cory-Slechta. "Developmental Lead Exposure and Prenatal Stress Result in Sex-Specific Reprograming of Adult Stress Physiology and Epigenetic Profiles in Brain". Toxicological Sciences 163, n.º 2 (21 de fevereiro de 2018): 478–89. http://dx.doi.org/10.1093/toxsci/kfy046.
Texto completo da fonteChen, Longmin, Jing Zhang, Yuan Zou, Faxi Wang, Jingyi Li, Fei Sun, Xi Luo et al. "Kdm2a deficiency in macrophages enhances thermogenesis to protect mice against HFD-induced obesity by enhancing H3K36me2 at the Pparg locus". Cell Death & Differentiation 28, n.º 6 (18 de janeiro de 2021): 1880–99. http://dx.doi.org/10.1038/s41418-020-00714-7.
Texto completo da fonteEid, Wassim, e Wafaa Abdel-Rehim. "Vitamin C promotes pluripotency of human induced pluripotent stem cells via the histone demethylase JARID1A". Biological Chemistry 397, n.º 11 (1 de novembro de 2016): 1205–13. http://dx.doi.org/10.1515/hsz-2016-0181.
Texto completo da fonteStojanovic, Lora, Rachel Abbotts, Kaushlendra Tripathi, Collin M. Coon, Sheng Liu, Jun Wan, Michael J. Topper, Kenneth P. Nephew, Stephen B. Baylin e Feyruz V. Rassool. "Abstract PR-005: ZNFX1 is a master regulator for epigenetic reprograming of mitochondrial inflammasome signaling and pathogen mimicry in cancer cells". Cancer Research 84, n.º 5_Supplement_2 (4 de março de 2024): PR—005—PR—005. http://dx.doi.org/10.1158/1538-7445.ovarian23-pr-005.
Texto completo da fontede Lima Camillo, Lucas Paulo, e Robert B. A. Quinlan. "A ride through the epigenetic landscape: aging reversal by reprogramming". GeroScience 43, n.º 2 (abril de 2021): 463–85. http://dx.doi.org/10.1007/s11357-021-00358-6.
Texto completo da fonteBae, Jooeun, Shuichi Kitayama, Zach Herbert, Laurence Daheron, Nikhil C. Munshi, Shin Kaneko, Jerome Ritz e Kenneth Carl Anderson. "Development of B-cell maturation antigen (BCMA)-specific CD8+ cytotoxic T lymphocytes using induced pluripotent stem cell technology for multiple myeloma." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junho de 2022): 2542. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.2542.
Texto completo da fonteBae, Jooeun, Shuichi Kitayama, Zach Herbert, Laurence Daheron, Nikhil C. Munshi, Shin Kaneko, Jerome Ritz e Kenneth Carl Anderson. "Development of B-cell maturation antigen (BCMA)-specific CD8+ cytotoxic T lymphocytes using induced pluripotent stem cell technology for multiple myeloma." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junho de 2022): 2542. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.2542.
Texto completo da fonteAlimova, Irina, Etienne Danis, Marla Weetall, Angela M. Pierce, Dong Wang, Natalie Serkova, Ilango Balakrishnan et al. "ATRT-06. SMARCB1 LOSS DRIVEN NON-CANONICAL PRC1 ACTIVITY REGULATES DIFFERENTIATION IN ATYPICAL TERATOID RHABDOID TUMORS (ATRT)". Neuro-Oncology 22, Supplement_3 (1 de dezembro de 2020): iii276—iii277. http://dx.doi.org/10.1093/neuonc/noaa222.006.
Texto completo da fonteTibana, Ramires, Octávio Franco, Rinaldo Pereira, James Navalta e Jonato Prestes. "Exercise as an Effective Transgenerational Strategy to Overcome Metabolic Syndrome in the Future Generation: Are We There?" Experimental and Clinical Endocrinology & Diabetes 125, n.º 06 (11 de maio de 2017): 347–52. http://dx.doi.org/10.1055/s-0042-120538.
Texto completo da fonteMasuda, Muneyuki, Hirofumi Omori, Kuniaki Sato, Josef Penninger e Silvio Gutkind. "Abstract PO-063: Environment-induced YAP1 transcriptional reprogramming drives head and neck cancer". Clinical Cancer Research 29, n.º 18_Supplement (15 de setembro de 2023): PO—063—PO—063. http://dx.doi.org/10.1158/1557-3265.aacrahns23-po-063.
Texto completo da fontePereira, Marcelo de Souza Fernandes, Yasemin Sezgin, Aarohi Thakkar e Dean Anthony Lee. "Tgfβ-Imprinting Decrease CD38 Expression and Lead to Metabolic Reprogramming on Primary NK Cell". Blood 136, Supplement 1 (5 de novembro de 2020): 4. http://dx.doi.org/10.1182/blood-2020-143085.
Texto completo da fonteChiang, Chi-Ling, Frank W. Frissora, Zhiliang Xie, Xiaomeng Huang, Rajeswaran Mani, Sivasubramanian Baskar, Christoph Rader et al. "Immunoliposomal Delivery of Mir-29b By Targeting Tumor Antigen ROR1 Induces Epigenetic Reprograming in Human-ROR1-Expressed Mouse Model of Chronic Lymphocytic Leukemia". Blood 126, n.º 23 (3 de dezembro de 2015): 1743. http://dx.doi.org/10.1182/blood.v126.23.1743.1743.
Texto completo da fonteBaranovski, Boris M., Gabriella S. Freixo-Lima, Eli C. Lewis e Peleg Rider. "T Helper Subsets, Peripheral Plasticity, and the Acute Phase Protein,α1-Antitrypsin". BioMed Research International 2015 (2015): 1–14. http://dx.doi.org/10.1155/2015/184574.
Texto completo da fonteByrne, Kristen A., Julian M. Trachsel, Zahra F. Bond, Jamison R. Slate, Brian J. Kerr, Bradley L. Bearson, Shawn M. Bearson e Crystal L. Loving. "Dietary β-glucan reduced Salmonella shedding, shifted intestinal microbiome, and altered intestinal integrity". Journal of Immunology 204, n.º 1_Supplement (1 de maio de 2020): 92.15. http://dx.doi.org/10.4049/jimmunol.204.supp.92.15.
Texto completo da fonte